TSJCI Annual Report 2021

Trinity St James’s Cancer Institute Annual Report 2021 22 1.13.2 Key Priorities for 2022 Improve our Day of Surgery Admission rates (DOSA): • Improve our DOSA rates in line national standards to include patients undergoing complex cancer based surgeries. This will be in conjunction with improved pre assessment access. Improved theatre through-put: • Improved theatre access and increased capacity via LEAN reviews and process design. • Increasing theatre footprint by two theatres with a submission to the HSE. Expansion of Advanced Nurse Practitioner posts across the directorate: • Particularly within Thoracic cancer, Critical Care and Head and Neck cancer. 1.13.2.1 Breast Care: • Improve and maintain continued access and compliance with key performance indicators (KPI) for the symptomatic breast service, providing an ‘end to end’ service, inclusive of reconstructive surgery. • Develop and resource with support from the NCCP, the Family Risk service. 1.13.2.2 Head and Neck Cancers: • The Hospital provides a service for 51% of the National Head and Neck patient cohort. The Directorate are planning to develop a ‘model of care’ for the service, securing appropriate resources which include plastics reconstructive surgery and Allied Health supports. 1.13.2.3 Thoracic Cancer: • Improve access for lung cancer surgery and compliance with key performance indicators, along with the continued development of Enhanced Recovery After Thoracic Surgery (ERATs) programme. Commencement of DOSA for lung surgery with a Nurse led PAC for Thoracic surgery, along with recruitment of an additional ANP. 1.13.2.4 Urology: • Develop the urology cancer service for all urological cancers and continue to maintain compliance with the prostate key performance indicators. This will be assisted by the recruitment of a new Consultant Urologist who will commence post in Q3 of 2022.